Assignee
LYNK PHARMACEUTICALS CO LTD
CN·12 granted patents·3 pending applications·2 citations·filing 2019–2024
Top patents by PatentIndex Score
15 records- 0191US11858933B2Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Jan 2, 2024·2 cites·23 claims
- 0286US2025115586A1Benzamides of pyrazolylamino- pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0385US12098142B2Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Sep 24, 2024·0 cites·11 claims
- 0485US12030870B2Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Jul 9, 2024·0 cites·16 claims
- 0585US11981663B2Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted May 14, 2024·0 cites·13 claims
- 0683US12516061B2Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2024·Granted Jan 6, 2026·0 cites·1 claims
- 0779US11851431B2Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Dec 26, 2023·0 cites·8 claims
- 0878US12595253B2Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2022·Granted Apr 7, 2026·0 cites·2 claims
- 0978US12421213B2Benzamides of pyrazolylamino- pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2022·Granted Sep 23, 2025·0 cites·14 claims
- 1076US12024503B2Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Jul 2, 2024·0 cites·13 claims
- 1171US12129250B2TYK2 inhibitors and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Oct 29, 2024·0 cites·22 claims
- 1270US2025115597A1Tyk2 inhibitors and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1363US12162866B1Crystal form of pyrazolyl-amino-pyrimidinyl derivative, and preparation method therefor and use thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Dec 10, 2024·0 cites·13 claims
- 1463US12024516B2Tricyclic janus kinase 1 inhibitors, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2019·Granted Jul 2, 2024·0 cites·5 claims
- 1555US2022259182A1Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LYNK PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →